Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis
- 1 October 1997
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 350 (9086), 1205-1209
- https://doi.org/10.1016/s0140-6736(97)05118-0
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- The Epidemiology Of Rotavirus Diarrhea In The United States: Surveillance And Estimates Of Disease BurdenThe Journal of Infectious Diseases, 1996
- Hospital Admissions Attributable To Rotavirus Infection In England And WalesThe Journal of Infectious Diseases, 1996
- Efficacy of Two Doses of RIT 4237 Bovine Rotavirus Vaccine for Prevention of Rotavirus DiarrhoeaActa Paediatrica, 1991
- Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central AfricaResearch in Virology, 1991
- Protective Effect of WC3 Vaccine Against Rotavirus Diarrhea in Infants During a Predominantly Serotype 1 Rotavirus SeasonThe Journal of Infectious Diseases, 1988
- Field trial of rhesus rotavirus vaccine in infantsThe Pediatric Infectious Disease Journal, 1988
- TRIAL OF AN ATTENUATED BOVINE ROTAVIRUS VACCINE (RIT 4237) IN GAMBIAN INFANTSThe Lancet, 1987
- PROTECTION AGAINST SEVERE ROTAVIRUS DIARRHOEA BY RHESUS ROTAVIRUS VACCINE IN VENEZUELAN INFANTSThe Lancet, 1987
- Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemicThe Journal of Pediatrics, 1985
- PROTECTION OF INFANTS AGAINST ROTAVIRUS DIARRHOEA BY RIT 4237 ATTENUATED BOVINE ROTAVIRUS STRAIN VACCINEThe Lancet, 1984